Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet

NCT00917644 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin
GENETIC: Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.